BiTE

Kerri FitzgeraldAcute Lymphoblastic Leukemia | November 16, 2022
The 2022 SOHO Annual Meeting kicked off with remarks from 2022-2023 President Moshe Talpaz, MD.
Read More
Leah SherwoodPrint | March 10, 2023
In his President's Letter, Moshe Talpaz, MD, discusses all of the treatment progress made for hematologic malignancies.
Leah LawrenceChronic Lymphocytic Leukemia | November 16, 2022
LAVA-051 consists of two single domain antibodies linked via a short five amino acid glycine-serine linker.
Advertisement
Kerri FitzgeraldChronic Lymphocytic Leukemia | February 1, 2023
The phase I/II study included patients with relapsed/refractory CLL or MCL who received two or more prior systemic therapies.
Advertisement
Advertisement
Advertisement
Editorial Board